Clinical Trial Update: Ketamine Continuous Infusion on Opioid Consumption and Pain Management in Severe Burned Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating continuous ketamine infusion for opioid consumption and pain management in severe burn patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pain, Burning | Phase 3 | Status: WITHDRAWN